Evaluación del grado de congestión clínica y hemodinámica como predictores de mortalidad en pacientes ambulatorios con insuficiencia cardíaca de edad avanzada

Gil-Martínez, P; Curbelo, J; Roy-Vallejo, E; Mesado-Martínez, D; Ciudad-Sañudo, M; Suárez-Fernández, C.
Rev. clín. esp. (Ed. impr.) ; 222(7): 377-384, ago. - sept. 2022. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-207419

Documentos relacionados

  1. Estimation of B-type Natriuretic Peptide Values from N-Terminal proBNP Levels.
  2. Development of an SI-traceable N-terminal pro-B-type natriuretic peptide certified reference material using structure-based impurity-corrected isotope dilution mass spectrometry approaches.
  3. [Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction].
  4. Galectin-3, Acute Kidney Injury and Myocardial Damage in Patients With Acute Heart Failure.
  5. [Predictive value of NT-proBNP on admission on left ventricular ejection fraction and in-patients major adverse cardiac and cerebrovascular events in hospitalized patients with unstable angina].
  6. A chemiluminescence immunoassay for the detection of NT-proBNP.
  7. [Value of N-terminal pro brain natriuretic peptide in predicting acute kidney injury in patients with acute decompensated chronic heart failure].
  8. Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure.
  9. Biomarker developments in heart failure: 2016 and beyond.
  10. Comparison of dialysate and plasma NTproBNP in prediction of clinical outcomes of diabetic and nondiabetic peritoneal dialysis patients
.